Use of Medicare Administrative Claims to Identify a Population at High Risk for Adverse Drug Events and Hospital Use for Quality Improvement

被引:9
|
作者
Digmann, Rachel [1 ]
Thomas, Anita [2 ]
Peppercorn, Sherry [4 ]
Ryan, Amanda [3 ]
Zhang, Lijing [4 ]
Irby, Kimberly [4 ]
Brock, Jane [4 ]
机构
[1] Telligen, Des Moines, IA USA
[2] Ctr Medicare & Medicaid Serv, Baltimore, MD USA
[3] Qsource, Memphis, TN USA
[4] Telligen, Greenwood Village, CO USA
来源
关键词
EMERGENCY-DEPARTMENT VISITS;
D O I
10.18553/jmcp.2019.25.3.402
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BACKGROUND: A system using administrative claims to monitor medication use patterns and associated adverse events is not currently available. Establishment of a standardized method to identify Medicare beneficiaries at high risk for adverse events, by assessing Medicare Part D medication claim patterns and associated outcomes, including outpatient adverse drug events (ADEs) and hospital use, enhances prevention efforts and monitoring for quality improvement efforts. OBJECTIVES: To (a) demonstrate that Medicare claims data can be used to identify a population of beneficiaries at high risk for adverse events for quality improvement and (b) define trends associated with adverse health outcomes in identified high-risk beneficiaries for quality improvement opportunities. METHODS: We used Medicare fee-for-service Part D claims data to identify a population at high risk for adverse events by evaluating medication use patterns. This population was taking at least 3 medications, 1 of which was an anticoagulant, an opioid, or an antidiabetic agent. Next, we used associated Part A claims to calculate rates of outpatient ADEs, looking for specific ICD-9-CM or ICD-10-CM codes in the principal diagnosis code position. Rates of hospital use (inpatient hospitalization, observation stays, emergency department visits, and 30-day rehospitalizations) were also evaluated for the identified high-risk population. The data were then shared for targeted quality improvement. RESULTS: We identified 8,178,753 beneficiaries at high risk for adverse events, or 20.7% of the total eligible fee-for-service population (time frame of October 2016-September 2017). The overall rate of outpatient ADEs for beneficiaries at high risk was 46.28 per 1,000, with anticoagulant users demonstrating the highest rate of ADEs (68.52/1,000), followed by opioid users (42.11/1,000) and diabetic medication users (20.72/1,000). As expected, the primary setting for beneficiaries at high risk to seek care for outpatient ADEs was the emergency department, followed by inpatient hospitalizations and observation stays. CONCLUSIONS: Medicare claims are an accessible source of data, which can be used to establish for quality improvement a population at high risk for ADEs and increased hospital use. Using medication use patterns to attribute risk and associated outcomes, such as outpatient ADEs and hospital use, is a simple process that can be readily implemented. The described method has the potential to be further validated and used as a foundation to monitor population-based quality improvement efforts for medication safety. Copyright (C) 2019, Academy of Managed Care Pharmacy. All rights reserved.
引用
收藏
页码:402 / 410
页数:9
相关论文
共 50 条
  • [41] Nonsteroidal antiinflammatory drug (NSAID) use in patients at high risk for adverse GI events: A managed care (MC) perspective.
    Mark, S
    GASTROENTEROLOGY, 1998, 114 (04) : A28 - A28
  • [42] Machine learning as a tool to identify inpatients who are not at risk of adverse drug events in a large dataset of a tertiary care hospital in the USA
    Langenberger, Benedikt
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (12) : 3523 - 3538
  • [43] USE OF A RISK MODEL TO IDENTIFY HEART FAILURE PATIENTS AT HIGH RISK FOR IN-HOSPITAL MORTALITY AND READMISSION
    Mohamed, Mohamed
    Stanberry, Larissa
    Garberich, Ross
    Bennett, Mosi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 841 - 841
  • [44] Use of a hospital administrative database to identify and characterize community-acquired, hospital-acquired and drug-induced acute kidney injury
    Rey, Amayelle
    Gras-Champel, Valerie
    Balcaen, Thibaut
    Choukroun, Gabriel
    Masmoudi, Kamel
    Liabeuf, Sophie
    JOURNAL OF NEPHROLOGY, 2022, 35 (03) : 955 - 968
  • [45] Use of a hospital administrative database to identify and characterize community-acquired, hospital-acquired and drug-induced acute kidney injury
    Amayelle Rey
    Valérie Gras-Champel
    Thibaut Balcaen
    Gabriel Choukroun
    Kamel Masmoudi
    Sophie Liabeuf
    Journal of Nephrology, 2022, 35 : 955 - 968
  • [46] Improvement in the detection of adverse drug events by the use of electronic health and prescription records: An evaluation of two trigger tools
    Ugochi Nwulu
    Krishnarajah Nirantharakumar
    Rachel Odesanya
    Sarah E. McDowell
    Jamie J. Coleman
    European Journal of Clinical Pharmacology, 2013, 69 : 255 - 259
  • [47] Improvement in the detection of adverse drug events by the use of electronic health and prescription records: An evaluation of two trigger tools
    Nwulu, Ugochi
    Nirantharakumar, Krishnarajah
    Odesanya, Rachel
    McDowell, Sarah E.
    Coleman, Jamie J.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (02) : 255 - 259
  • [48] Assessment of Adverse Drug Reactions to Off-Label Drug Use in an Oncological Population Treated in a Northern Italian Hospital
    Piccoli, L.
    Cazzador, F.
    Coppola, M.
    Berti, E.
    DRUG SAFETY, 2022, 45 (10) : 1256 - 1256
  • [49] Quality improvement initiative: use of the STOP-BANG score and monitoring to reduce adverse events in hospitalised patients at risk of obstructive sleep apnoea
    Lauer, Kathryn K.
    Zhang, Donglin
    Lunar, Lauren
    Landry, Curtis
    Welter, Jennifer
    Flemming, Kellianne
    Franco, Rose
    Siclovan, Danielle
    Avdeev, Jamie
    Woodson, B. Tucker
    Szabo, Aniko
    Truwit, Jonathon D.
    Hainsworth, Keri R.
    BMJ OPEN QUALITY, 2024, 13 (04)
  • [50] Evaluation the Use of Potentially Inappropriate Medications in Older Adults to Reduce the Risk of Adverse Drug Events Comment
    Hwang, Lee-Ching
    INTERNATIONAL JOURNAL OF GERONTOLOGY, 2022, 16 (04) : 315 - 315